[Form 4] The Sherwin-Williams Company Insider Trading Activity

Rhea-AI Filing Summary

Sherwin-Williams (SHW) Form 4 filing overview

Sherwin-Williams director Kerrii B. Anderson reported a small, routine acquisition of deferred stock units on 7 July 2025 under the company’s 2005 Director Deferred Fee Plan. The filing shows:

• Transaction: 28.86 deferred stock units (economic equivalent of one common share each) were credited to Anderson’s account at a weighted-average reference price of $346.53.
• Nature: Exempt, automatic deferral of director fees rather than an open-market share purchase; units become payable in common stock after Anderson leaves the board.
• Post-transaction beneficial ownership: 948.59 deferred stock units held indirectly through the plan, plus 5,261 directly held equity interests (4,111 common shares and 1,150 restricted stock units).
• Ownership status: Anderson remains a non-executive director and files individually.

The activity is de minimis relative to Sherwin-Williams’ 255 million share count and does not signal a directional view on the stock. It is primarily an administrative conversion of board fees into equity and therefore carries limited investment significance.

Insights

Securities Analyst

TL;DR: Routine fee deferral; negligible impact on SHW valuation.

The acquisition of 28.86 deferred stock units by director Kerrii Anderson is a standard, fee-in-kind election under Sherwin-Williams’ Director Deferred Fee Plan. Because no cash was deployed and the units cannot be sold until after board service ends, the filing does not reflect an active insider purchase conviction. Beneficial holdings rose marginally to 948.59 units, alongside 5,261 equity interests already owned. With total consideration below $10,000 and less than 0.00004% of shares outstanding, the event is immaterial to liquidity, float or governance. Overall impact for investors is neutral; no strategic or financial information about the company is provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ANDERSON KERRII B

(Last) (First) (Middle)

101 W. PROSPECT AVENUE

(Street)

CLEVELAND OH 44115

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHERWIN WILLIAMS CO [ SHW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/07/2025		A		28.86(1)	A	$346.53(2)	948.59(3)	I	Deferred Fee Plan
Common Stock								5,261(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of deferred stock units acquired by the Reporting Person, in an exempt transaction, pursuant to the 2005 Director Deferred Fee Plan ("Deferred Fee Plan"). Each deferred stock unit is the economic equivalent of one share of common stock. The deferred stock units become payable solely in stock, generally following the Reporting Person's separation from service as a Director of the Company.

2. Represents the weighted average share price on the transaction date used to determine the number of deferred stock units credited to the Reporting Person's account.

3. These securities consist of deferred stock units, held pursuant to the Deferred Fee Plan, and include deferred stock units acquired pursuant to the dividend reinvestment feature of such Plan.

4. These securities consist of 1,150 restricted stock units ("RSUs") and 4,111 shares of common stock. Each RSU represents the Reporting Person's right to receive one share of common stock.

Remarks:

	Stephen J. Perisutti, Attorney-in-fact	07/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Sherwin-Williams director Kerrii Anderson acquire on 07/07/2025?

28.86 deferred stock units under the 2005 Director Deferred Fee Plan, each equivalent to one share of SHW common stock.

How many Sherwin-Williams shares and units does Anderson now own?

After the transaction, Anderson holds 948.59 deferred stock units indirectly and 5,261 equity interests directly (4,111 shares + 1,150 RSUs).

Was the transaction submitted under a Rule 10b5-1(c) trading plan?

Yes. The filing is marked as being executed under a Rule 10b5-1 compliant plan for fee deferrals.

Does this Form 4 imply insider confidence in SHW stock?

Not materially. It reflects automatic fee deferral rather than a discretionary share purchase.

Is the reported transaction likely to affect Sherwin-Williams’ share price?

No. The small size and administrative nature of the transaction make it immaterial to market supply and demand.